0245-0823 : Torpenz 5 mg Oral Tablet


NDC: 0245-0823
Labeler: Upsher-smith Laboratories, LLC
Product Type: Human Prescription Drug
Drug Name:  Torpenz
Dosage Form: Oral Tablet
Application #: ANDA214182
Rev. Date: 


NDC Package Codes:

  • 0245-0823-30: 30 TABLET IN 1 BOTTLE (0245‑0823‑30)

Active Ingredients:

  • Everolimus

Dosage Strength:

  • 5 mg

Pharmaceutical Classes:

  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Decreased Immunologic Activity [PE]
  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]
  • mTOR Inhibitor Immunosuppressant [EPC]
  • mTOR Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0245-0822 Torpenz 2.5 mg Oral Tablet by Upsher-smith Laboratories, LLC
  • 0245-0824 Torpenz 7.5 mg Oral Tablet by Upsher-smith Laboratories, LLC
  • 0245-0825 Torpenz 10 mg Oral Tablet by Upsher-smith Laboratories, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0245-0823 QR Code

< Prev: 0245-0822Next: 0245-0824 >

Related Discussions:

Everolimus Face Rash
Side Effects of Everolimus including face and body rash; swollen feet...
Everolimus Side Effects
Everolimus Side Effects: Face and Body Rash...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.